PPP

PEPTONIC MEDICAL AB

No trades
See on Supercharts
Market capitalization
‪18.73 M‬SEK
−0.0416SEK
‪−42.59 M‬SEK
‪37.12 M‬SEK
Beta (1Y)
−1.01

About PEPTONIC MEDICAL AB

CEO
Erik Sundquist
Headquarters
Bromma
Employees (FY)
38
Founded
2009
ISIN
SE0005962206
FIGI
BBG006K9QLS9
Peptonic Medical AB engages in the development of oxytocin based products for the treatment of menopausal symptoms. It develops Vagitocin, which focuses on the treatment of vaginal atrophy. The company was founded by Kerstin Uvnas Moberg and Ronald Eric Long on December 2, 2008 and is headquartered in Bromma, Sweden.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of PMED is 0.0158 SEK — it has increased by 9.72% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NGM exchange PEPTONIC MEDICAL AB stocks are traded under the ticker PMED.
PMED stock is 18.92% volatile and has beta coefficient of −1.01. Check out the list of the most volatile stocks — is PEPTONIC MEDICAL AB there?
Yes, you can track PEPTONIC MEDICAL AB financials in yearly and quarterly reports right on TradingView.
PMED stock has risen by 19.70% compared to the previous week, the month change is a 64.89% fall, over the last year PEPTONIC MEDICAL AB has showed a 81.19% decrease.
PMED net income for the last quarter is ‪−19.62 M‬ SEK, while the quarter before that showed ‪−7.49 M‬ SEK of net income which accounts for −161.84% change. Track more PEPTONIC MEDICAL AB financial stats to get the full picture.
Today PEPTONIC MEDICAL AB has the market capitalization of ‪22.10 M‬, it has decreased by 68.60% over the last week.
No, PMED doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PMED shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PEPTONIC MEDICAL AB stock right from TradingView charts — choose your broker and connect to your account.
PMED reached its all-time high on Jul 29, 2015 with the price of 8.4010 SEK, and its all-time low was 0.0108 SEK and was reached on Apr 17, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 26, 2024, the company has 38.00 employees. See our rating of the largest employees — is PEPTONIC MEDICAL AB on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PEPTONIC MEDICAL AB technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PEPTONIC MEDICAL AB stock shows the sell signal. See more of PEPTONIC MEDICAL AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PEPTONIC MEDICAL AB EBITDA is ‪−34.19 M‬ SEK, and current EBITDA margin is −92.10%. See more stats in PEPTONIC MEDICAL AB financial statements.